Alflox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alflox

Quick Facts About Alflox

Property Description
Active Ingredient Norfloxacin
Form Tablets, Film-coated tablets
Pharmacological Class Fluoroquinolone Antibiotic
General Purpose Anti-infective agent for bacterial infections
Origin Synthetic compound

Alflox: Definition and Pharmacological Classification

Alflox is a medication containing the active ingredient Norfloxacin, a highly potent synthetic antibacterial agent used to combat microbial pathogens. Norfloxacin belongs to the class of fluoroquinolone antibiotics, which are members of the broader quinolone antimicrobial family. This classification signifies its role as an anti-infective drug designed to address the presence of systemic bacterial infections. Norfloxacin is utilized as a cornerstone antibacterial agent for its intended applications.

Composition, Origin, and Dosage Form

The composition of Alflox is based on Norfloxacin as the sole active ingredient, making it a single-ingredient product (monotherapy). Norfloxacin itself is a synthetic compound, chemically defined by its core structure C16H18FN3O3. This synthetic antibacterial agent is routinely manufactured for oral administration and is supplied as solid tablets or film-coated tablets, formulated with necessary pharmaceutical excipients. The film-coated characteristic is a design feature intended to enhance patient compliance and ensure the active substance is protected until reaching the gastrointestinal tract.

The General Purpose of Norfloxacin

The general therapeutic purpose of Norfloxacin is to achieve the swift, irreversible elimination of susceptible bacteria through bactericidal action. This broad-spectrum antibacterial agent functions by disrupting the genetic machinery of the microorganism, leading to the inhibition of essential bacterial DNA synthesis. Consequently, the medicine's role is to resolve the underlying bacterial infection by effectively neutralizing the responsible pathogens. Its use is typically reserved for adult patients requiring prescription-only treatment for susceptible bacterial illnesses.

What side effects are possible with Alflox?

Possible side effects and safety information

The safety profile of Alflox (Norfloxacin) is formally organized by regulatory authorities to classify potential adverse reactions based on frequency and affected system. These classifications establish a regulatory hierarchy of risk, encompassing both common events and serious adverse reactions.


Documented Adverse Reaction Categories

Side effects are grouped by their statistical occurrence and the physiological system affected. Common reactions documented in regulatory sources include nausea, headache, dizziness, and increases in liver enzymes. Uncommon events may involve gastrointestinal disturbances, insomnia, or anxiety. Rare occurrences are critical and include the most severe safety concerns.

Classification System-Organ Classes Involved (SOC)
Common Gastrointestinal, Nervous System, Hepatobiliary
Rare Musculoskeletal, Cardiac, Nervous System, Immune System

Serious Adverse Reactions and Safety Constraints

The official label highlights several rare but clinically significant adverse reactions. These include tendinopathy and tendon rupture, which may occur during treatment or up to several months after discontinuation. Other serious risks involve peripheral neuropathy (which can be persistent), convulsions, psychotic reactions, and serious heart rhythm abnormalities like QTc prolongation.

Specific population-based safety constraints are documented. The medicine is generally contraindicated in children and growing adolescents. Older adults and patients co-administering corticosteroids have an increased risk of tendon damage. The regulatory profile also notes that symptoms of peripheral neuropathy and certain CNS effects may manifest soon after initiation or after the first dose.

Overdose and Emergency Response

Alflox Overdose and when to seek help

The regulatory profile for Alflox (norfloxacin) overdose outlines the documented clinical signs, the potential for severe organ toxicity, and the required emergency response.

Category Official Regulatory Statement
Documented overdose presentations Gastrointestinal disturbances (vomiting, diarrhoea) and Central Nervous System effects, including dizziness, tinnitus, and convulsions.
Physiological systems affected Renal function, Hepatic function, Cardiovascular system (due to risk of QT interval prolongation).
Emergency-response statements Seek emergency medical attention immediately or call a healthcare provider immediately.
When immediate medical help is required Urgent medical assistance is required upon the ingestion of a dose considered excessive or in the event of significant poisoning.

Official overdose statements and management: Overdose may present with documented CNS effects such as convulsions, dizziness, and tinnitus. In cases of significant poisoning, official documents cite the potential for severe outcomes, including acute renal failure and liver damage. Management is primarily symptomatic and supportive, as no specific antidote is known for norfloxacin overdose. Procedural guidance includes the potential use of activated charcoal and gastric decontamination. Continuous monitoring of renal, hepatic function, and the cardiovascular system is necessary due to the documented risks of organ damage and the potential for QT interval prolongation. This potential for severe harm establishes the necessity of seeking immediate medical attention.

Therapeutic Uses of Alflox

What Alflox Treats: Main Uses and Benefits

Alflox (norfloxacin) is an antimicrobial agent prescribed to assist in the management of bacterial infections, as determined by a healthcare professional.


Quick Facts

  • May be used for: Bacterial infections of the urinary system.
  • Indicated for: Certain gastrointestinal infections, such as traveler’s diarrhea.
  • Prescribed for: Management of gonococcal infections, which are sexually transmitted.
  • Applies to: Specified instances of prostatitis (inflammation of the prostate).

Therapeutic Overview

Alflox is a treatment option intended to address infections caused by susceptible organisms. Its primary therapeutic domains include infections affecting the urinary tract, such as cystitis and pyelonephritis, when alternative treatments are not appropriate. The medication is also utilized in specific cases of prostatitis and the management of certain forms of gonorrhea. Furthermore, it is prescribed for the purpose of controlling gastrointestinal infections, which may encompass traveler's diarrhea. Appropriate use of this class of medication is generally reserved for situations where other treatment alternatives are not available, due to potential risks.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Alflox

Alflox (Norfloxacin) eligibility is strictly defined by regulatory documents, distinguishing between populations permitted for standard use, those for whom use is contraindicated, and those requiring special consideration. Standard use is generally established only for adult patients.

Eligibility Status Key Restriction
Contraindicated Individuals with a history of hypersensitivity to norfloxacin or any other fluoroquinolone antimicrobial agent. Patients with a history of tendon rupture linked to fluoroquinolone use, or a known diagnosis of myasthenia gravis.
Not Recommended Children and adolescents under 18 years of age (safety and efficacy are not established). Pregnant or breastfeeding women due to regulatory concerns.

Conditional Eligibility and Restrictions

Use is restricted and requires careful regulatory evaluation for patients with certain pre-existing conditions. These include individuals with severe renal impairment and those with risk factors for QTc prolongation, such as uncorrected hypokalemia. Patients with a history of seizures or solid organ transplant recipients are also subject to specific restrictions due to increased risk profiles documented in official labeling.

What should I know about interactions with other medicines?

The official regulatory profile for Alflox (norfloxacin) documents several classes of interactions that govern its co-administration with other medicines and products.

Interaction-Related Restrictions

Classification Interacting Agents Constraint or Requirement
Contraindicated Tizanidine Co-administration is formally prohibited due to the risk of significantly increasing Tizanidine plasma concentrations.
Avoidance Class IA and III Antiarrhythmics (e.g., Amiodarone, Sotalol) Co-administration should be avoided due to the documented additive risk of QTc interval prolongation.
Avoidance Corticosteroids Co-administration should be avoided due to an increased pharmacodynamic risk of tendon rupture.
Not Recommended Nitrofurantoin Co-administration is not recommended due to possible antagonism of the antibacterial effect in the urinary tract.

Pharmacokinetic and Timing Rules

Alflox absorption is reduced by several substances through a chelation mechanism in the gastrointestinal tract, resulting in lower systemic exposure. The regulatory label mandates timing constraints for these agents:

  • Mandatory Separation: Products containing Magnesium, Aluminum, Iron, or Zinc (e.g., antacids, multivitamins, sucralfate, certain Didanosine formulations) must not be taken within the two-hour period immediately before or after the administration of Alflox.

Norfloxacin inhibits Cytochrome P450 1A2 (CYP1A2) metabolism, which can lead to elevated plasma concentrations of substrates like Theophylline and Caffeine.

Pharmacodynamic Effects and Monitoring

  • Oral Anticoagulants (e.g., Warfarin) may have their effects enhanced; coagulation tests (e.g., INR) must be closely monitored when co-administered.
  • Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may increase the risk of CNS stimulation and convulsive seizures.
  • Caution is advised in patients with risk factors for QTc prolongation when using other QT-prolonging drugs.

Mechanism of Action

Targeting Bacterial DNA Gyrase and Topoisomerase IV

Alflox (Norfloxacin) exerts its effect by targeting two essential bacterial enzymes: DNA Gyrase (DNA Topoisomerase II) and Topoisomerase IV. These enzymes are required for processes including DNA unwinding, supercoiling, and the separation of replicated chromosomes. The drug functions as an inhibitor, forming a stabilized complex with the enzyme and the cleaved DNA strands.

The Cascade of Irreversible DNA Damage

The stable binding of Norfloxacin to its targets prevents the enzymes from resealing the temporary breaks in the DNA backbone. This mechanical block leads to the accumulation of numerous double-stranded DNA breaks, overwhelming the bacterium's repair systems and blocking DNA replication and cell division. This cascade of irreversible molecular damage directly results in the bactericidal effect, meaning the targeted destruction of susceptible bacterial cells.

Constraints on the Mechanism of Action

The effectiveness of this bactericidal mechanism can be constrained by specific biological defense mechanisms within the bacterial cell. These include Efflux Pumps, which actively transport the drug out of the cell before it reaches its target, and Target Enzyme Mutations, which structurally change the binding site on DNA Gyrase and Topoisomerase IV. These limitations reduce the effective intracellular concentration or binding affinity, functionally compromising the molecular cascade that leads to the lethal DNA breaks.

Dosage and Administration Information

How to Use Alflox (Norfloxacin)

The administration of Alflox, containing the active ingredient norfloxacin, follows specific established protocols. This section describes the standard parameters for use, based on the route, dosing, and required timing.

Instruction Domain Protocol
Route of Administration Oral ingestion of the tablet form.
Standard Dosing 400 mg typically taken twice daily, or 800 mg as a single dose for specific infections.
Duration of Course Varies by indication, ranging from a single dose to a course of up to 28 days.
Renal Adjustment For severe renal impairment (CrCl le 30 mL/min), the dosage is reduced to 400 mg once daily.

Procedural Conditions for Intake

The medication is administered following specific procedural steps to optimize its use:

  1. Timing with Food: Each tablet must be taken on an empty stomach—at least one hour before or two hours after meals, milk, or other dairy products.
  2. Separation from Cations: The dose must be separated by at least two hours from the intake of products containing iron, zinc, magnesium, or aluminum, such as antacids.
  3. Fluid Intake: Swallowing the tablet with a full glass of water is required, and patients must ensure adequate daily fluid intake throughout the treatment period.

The use protocol is structured around these time-dependent and physical constraints. Following these rules regarding frequency, dose, and separation from other substances defines the standardized administration of norfloxacin.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Alflox (Norfloxacin)

Evidence for Use in Urinary Tract and Recurrent Infections

Alflox was studied for managing infections of the urinary tract, which are conditions characterized by fluctuating or episodic manifestations. Research in this area primarily involves short-term Randomized Controlled Trials (RCTs) and systematic reviews, comparing Norfloxacin to either a placebo or other active antimicrobial agents. These studies largely included adult women experiencing uncomplicated cystitis (a lower UTI). The outcomes monitored were measurements of microbial status and outcomes related to physical discomfort, with researchers tracking patterns of symptom evolution. For recurrent UTIs, long-term prophylaxis studies were applied, monitoring participants for up to a year to examine the incidence of recurrent infection episodes. Data show patterns related to the frequency of new episodes tracked in the studied populations.

Evidence for Use in Preventing Spontaneous Bacterial Peritonitis (SBP)

Alflox was studied for the specific use in SBP prophylaxis, a serious infection in high-risk populations, primarily adults with liver cirrhosis and ascites. The studies employed long-term RCTs and meta-analyses, often spanning 6 to 12 months. Research examined not only the incidence of new SBP episodes but also broader outcomes reflecting daily functioning or activity level, including overall patient outcomes monitored. Studies monitored patterns related to SBP incidence compared to control groups in high-risk patients.

What Remains Unclear or Uncertain About the Evidence Base

One major concern is the ongoing impact of increasing bacterial resistance to this class of medication, which is a concern documented in research regarding potential changes in observed patterns over time. Furthermore, comparative evidence is lacking that directly explores Alflox against newer, current standard-of-care treatments for all approved uses. For some historical indications, such as complicated pyelonephritis, evidence remains limited, and certainty remains low due to the scarcity of high-quality contemporary trials. Results apply only to the populations studied in the original trials.

Frequently Asked Questions (FAQ)

Common questions about Alflox (FAQ)

Q: What is Alflox most commonly prescribed for?

A: According to official regulatory documents, Alflox (Norfloxacin) is formally approved for managing specific bacterial infections. These uses typically include certain types of urinary tract infections (UTIs) and, for certain high-risk populations, for the prevention of spontaneous bacterial peritonitis (SBP).

Q: How long do I need to take Alflox for?

A: The required duration of treatment varies based on the specific infection being addressed. Official regulatory guidance indicates that treatment can range from a single dose for some conditions to courses lasting up to 28 days for others.

Q: What if Alflox doesn't seem to be working for me?

A: Official safety information suggests that a lack of effect may be related to the bacteria developing resistance to the drug. This can happen if the bacteria change in a way that makes the drug less effective. Reduced effectiveness can also occur if the medicine is not absorbed properly due to interactions.

Q: Is Alflox a generic or a brand-name medicine?

A: Alflox is the brand name given to the drug containing the active ingredient Norfloxacin. The medicine is also available as a generic product, which means it contains the same active ingredient.

Q: Can I stop taking Alflox as soon as I feel better?

A: Official instructions indicate that completing the full prescribed course is necessary. Stopping early, even if symptoms improve, is associated with the risk of the infection returning and potentially contributing to the development of drug-resistant bacteria.

Q: Does Alflox need to be stored in the refrigerator?

A: The official storage requirements state that Alflox should be kept at controlled room temperature, usually between 15 C and 30 C (59 F and 86 F). The medicine must be protected from light and moisture, and should not be frozen or refrigerated.

Q: How does taking Alflox affect driving or operating machinery?

A: The medication has been associated with central nervous system side effects such as dizziness, light-headedness, confusion, or anxiety. Due to these potential effects, official documents recommend caution when performing tasks that require mental alertness, such as driving or operating machinery.

Q: Can Alflox affect the results of blood tests?

A: Official prescribing information reports that Alflox has been associated with certain temporary laboratory changes. These noted changes may include increases in liver enzyme levels (ALT/AST) and alterations in white blood cell or platelet counts.

Q: Does Alflox make you feel sleepy?

A: The official label reports that certain nervous system effects may occur, including insomnia (trouble sleeping) and, in some cases, dizziness, which can affect overall alertness. Sleepiness (somnolence) itself is not a frequently listed effect.

Q: Can I drink coffee while on Alflox?

A: Official drug interaction information indicates that Alflox can slow down the way the body processes caffeine, which may lead to increased levels of caffeine in the body. Official documents note that limiting consumption of caffeine-containing products may be necessary to avoid increased effects such as restlessness or nervousness.

Q: What is the shelf life of Alflox?

A: The shelf life for Norfloxacin tablets, as noted in regulatory data sheets, is typically between 18 and 24 months. This duration applies only when the medicine is stored exactly according to the specified conditions of controlled room temperature and protection from moisture.

Q: Is it normal to feel a mild headache when starting Alflox?

A: Headache is listed in official documents as a common adverse reaction associated with the medicine. Certain side effects, including those affecting the nervous system, are documented to appear soon after starting treatment.

Q: Are there any long-term effects associated with Alflox use?

A: The official label documents rare but serious adverse reactions, such as tendon rupture and peripheral neuropathy (nerve damage), that may occur during treatment. These effects can sometimes persist for several months after discontinuing the medicine.

Q: How does Alflox affect the liver or kidneys?

A: Norfloxacin is primarily eliminated from the body by the kidneys. Official documents indicate that dose adjustments are necessary for individuals with severe kidney impairment. Common side effects include temporary increases in liver enzymes; while rare, serious adverse events involving the liver have also been reported.

Q: Are there different strengths of Alflox tablets?

A: Official regulatory documents list the availability of Norfloxacin in multiple dosage strengths. This typically includes 400 mg tablets and, for specific approved uses, 800 mg strengths.

Q: Does Alflox have a risk of allergic reaction?

A: Hypersensitivity (an allergic reaction) to Alflox or any other drug in its class (fluoroquinolones) is a formal contraindication for use. Severe allergic reactions, including anaphylaxis and swelling, are rare but officially documented safety risks.

Q: Does Alflox contain gluten or lactose?

A: The active ingredient, Norfloxacin, is often manufactured with non-active components called excipients. While formulations can vary, the full ingredient documents for Norfloxacin typically list lactose monohydrate as a common excipient.

Q: Why do some people need to take Alflox for a long time?

A: Longer-term courses are described in official documents when the medicine is used for prophylaxis, meaning prevention. This includes preventing recurrent infections or preventing spontaneous bacterial peritonitis in specific high-risk patient groups.

Q: Can Alflox make your skin more sensitive to the sun?

A: Official labeling documents the risk of photosensitivity or phototoxicity reactions. This means that using Alflox may cause the skin to become more sensitive to exposure from the sun or other ultraviolet (UV) light sources.

Q: What is the typical age range of people using Alflox?

A: The medication is formally contraindicated, or not recommended for use, in children and adolescents under 18 years of age. This restriction establishes that its use is officially limited to the adult patient population.

Q: How long does Alflox stay in your system after stopping it?

A: The clearance of the medicine is measured by its half-life, which is the time it takes for half of the drug to be eliminated from the body. The half-life for Norfloxacin is approximately 3 to 4 hours in people with normal kidney function, meaning it takes several half-life periods for the drug to be substantially cleared.

Q: Can I take Alflox if I have a history of heart problems?

A: Caution is officially documented, and the use of the drug is generally restricted for patients with a history of certain heart conditions. This includes known QT prolongation or uncorrected low potassium, due to the documented risk of serious heart rhythm abnormalities.

Q: Are there specific times of day Alflox should be taken?

A: The official protocol is structured around taking the medication at evenly spaced intervals to maintain consistent drug levels. This timing is relative to the previous dose and is not tied to specific non-clinical times like 'morning' or 'evening.'

Q: Is there a documented reversal agent for Alflox overdose?

A: Official regulatory documents do not list a specific antidote or reversal agent for an overdose of Alflox. Management of overdose involves general supportive care measures, such as monitoring the patient and ensuring adequate hydration.

Q: Why does the packaging for Alflox say 'use with caution' for certain conditions?

A: Special warnings of caution are mandated for patients with pre-existing risk factors, such as a history of seizures, existing severe kidney impairment, or risk factors for QTc prolongation. These warnings are required because those conditions may increase the patient’s risk of serious side effects.

How should Alflox be stored and disposed of?

Storage and Disposal of Norfloxacin Tablets

Norfloxacin tablets (the active ingredient in Alflox) must be stored according to regulatory requirements to ensure stability.

Storage Conditions

Item Requirement
Temperature Store at Controlled Room Temperature (15 C to 30 C / 59 F to 86 F).
Protection Protect from light and moisture. Do not freeze or refrigerate.
Container Keep the container tightly closed and store in the original packaging.
Child Safety Keep out of the reach and sight of children.

Disposal Instructions

Disposal of unused or expired tablets should follow official local regulations. The preferred method is using a drug take-back program. If a take-back option is unavailable, the tablets must be mixed with an undesirable substance, placed in a sealed bag or container, and discarded in the household trash, as Norfloxacin is not on the list of medicines to be flushed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alflox found in:

A-Z Index: